As first reported by Reuters, GoodRx, the prescription drugs marketplace, has submitted paperwork with the U.S. Securities and Exchange Commission for a planned public listing. According to Reuters, the company is in the process of hiring advisers to arrange a public listing, which is said to be scheduled for later his year or early in 2021.

Apparently, GoodRx plans to go public after about nine years since its founding. The Santa Monica-based company was founded in 2011 by two entrepreneurs by the names of Doug Hirsch and Trevor Bezdek. GoodRx acts as a middleman that gathers information from pharmacy partners to help its users track drug prices and discounts. The company primarily makes money by charging fees to its more than 70,000 US-based pharmacy partners. According to GoodRx, some 17 million consumers make use of its service monthly.

GoodRx is backed by investors including Silver Lake Partners, Francisco Partners, and entertainment mogul Michael Ovitz. The company was said to be valued at $2.8 billion after an investment from Silver Lake in 2018.

GoodRx appointed a Chief Financial Officer just in June of this year. Currently, the company is known to have north of 300 employees in total.